PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

ELRIG UK Appoints Nick Clare to Board as Vendor Strategy Work Group Lead

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the appointment of Nick Clare to the ELRIG board. He will chair and lead the Vendo...
Continue Reading →
News

First patient dosed in pivotal CureVac flu vaccine study

Modified influenza vaccine candidates have been developed in collaboration with GSK. CureVac has announced that the first patient has been dosed in the phase 1 el...
Continue Reading →
News

Positive opinion for Gilead’s Hepcludex

The vital recommendation ensures marketing authorisation for treating the hepatitis delta virus. Gilead Sciences has announced that the Committee for Medicinal Pr...
Continue Reading →
News

Endogena finalises enrolment for retinitis pigmentosa trial

The treatment is a small molecule that activates endogenous retinal stem and progenitor cells Endogena Therapeutics has revealed that it has completed patient enr...
Continue Reading →
News

Ginkgo Bioworks, Boehringer Ingelheim partner on breakthrough therapies

Ginkgo Bioworks, a Boston-based biotech working on cell programming and biosecurity, announced this week that it has partnered with Boehringer Ingelheim to work on b...
Continue Reading →
News

Novavax to reduce workforce by 25%

Maryland-based vaccine maker Novavax announced this week that it will be reducing its workforce by 25%, in an effort to “scale to the endemic COVID opportunity.”  ...
Continue Reading →
News

Roche bets on Zion HER2 brain metastases prospect

Roche has acquired the global rights to Chinese biotech Zion Pharma's lead program, a drug designed to treat or prevent the onset of brain metastases in patients wit...
Continue Reading →
News

Explore The Latest Trends At PHARMAP 2023

Digital transformation, AI, Big Data and analytics, continuous manufacturing, additive manufacturing, advanced robotics and other industry trends are going to be dis...
Continue Reading →
News

VYNE and Tay Therapeutics reach licence agreement

The deal involves an oral BET inhibitor that treats fibrotic and immuno-inflammatory disorders. The University of Dundee-based Tay Therapeutics – a company focuse...
Continue Reading →
News

SporeGen and Destiny advance research collaboration

The duo has partnered on developing a biotherapeutic therapy for flu and COVID-19. Destiny Pharma – a company focused on the progression of novel medicines that c...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026